So-Young International Inc. (SY)
NASDAQ: SY · IEX Real-Time Price · USD
0.970
+0.007 (0.74%)
At close: Jul 19, 2024, 4:00 PM
0.930
-0.040 (-4.13%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
So-Young International Revenue
So-Young International had revenue of $209.20M in the twelve months ending March 31, 2024, with 13.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.21M. In the year 2023, So-Young International had annual revenue of $211.29M with 17.08% growth.
Revenue (ttm)
$209.20M
Revenue Growth
+13.37%
P/S Ratio
0.47
Revenue / Employee
$154,160
Employees
1,357
Market Cap
98.92M USD
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 211.29M | 30.82M | 17.08% |
Dec 31, 2022 | 180.47M | -83.98M | -31.76% |
Dec 31, 2021 | 264.45M | 66.44M | 33.55% |
Dec 31, 2020 | 198.01M | 33.49M | 20.36% |
Dec 31, 2019 | 164.52M | 75.20M | 84.18% |
Dec 31, 2018 | 89.32M | 50.13M | 127.89% |
Dec 31, 2017 | 39.20M | 32.08M | 450.93% |
Dec 31, 2016 | 7.11M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Xtant Medical Holdings | 101.23M |
Sensus Healthcare | 31.66M |
Omega Therapeutics | 4.94M |
Sagimet Biosciences | 2.00M |
VistaGen Therapeutics | 1.06M |
Oramed Pharmaceuticals | 674.00K |
Cardiff Oncology | 610.00K |
SY News
- 7 weeks ago - So-Young Reports Unaudited First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - So-Young to Report First Quarter 2024 Financial Results on May 28, 2024 - PRNewsWire
- 3 months ago - So-Young International Inc. Files Its Annual Report on Form 20-F - PRNewsWire
- 4 months ago - So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results - PRNewsWire
- 4 months ago - So-Young to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024 - PRNewsWire
- 7 months ago - So-Young Announces Update on Repurchase and Cancellation of Shares - PRNewsWire
- 7 months ago - Grant of Restricted Share Units to Mr. Xing Jin - PRNewsWire
- 8 months ago - So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business - PRNewsWire